Investors

People are different and so is their cancer, patients should be treated individually.

Latest News

Extended Partnership with Werfen strengthens 2cureX’s Iberian distribution network

Read more

Directed Issue 2020

Directed Issue 2020

Company presentation

Please click here to download our Company presentation

Structure of Directed Issue including warrants to current shareholders

Please click here to download structure of Directed Issue and warrants

Upcoming events

October 13, 2022

2cureX presents at Redeye Investor AW in Malmø, Sweden

Redeye events list

October 26, 2022

2cureX presents at Redeye Medtech event in Stockholm, Sweden

Redeye events list

November 24, 2022

Interim Report Q3 2022 released

View previous reports

November 24, 2022

Q3 Report webcast and Q&A session

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.

Read more